RxDoctor Payments DataLook up a doctor →

David Mayman

Orthopaedic Surgery · New York, NYNPI 1407882921

Payments from drug & device makers

$6,317,240in general payments, 2019–2025

Across 535 payments — averaging $11,808 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3.3M
  • Smith+Nephew$1.8M
  • Orthalign Inc$659K
  • Encore Medical, LP$528K
  • Globus Medical$414
  • Wishbone Medical Inc.$122
  • plus $424 from 9 others

What the payments were for

  • Royalty or licence$4,688,48886%
  • Consulting fees$167,2663%
  • Speaking & faculty fees$24,6850%
  • Travel & lodging$46,5281%
  • Food & beverage$12,0050%
  • Other$528,37410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,317,240 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam21$64
Amoxicillin16$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →